Brain Res Bull 1999, 48:203–209.PubMedCrossRef 44. selleck screening library Salter CA: Dietary tyrosine as an aid to stress resistance among troops. Mil Med 1989, 154:144–146.PubMed 45. Smith ML, Hanley WB, Clarke JT, Klim P, Schoonheyt W, Austin V, Lehotay DC: Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.

Arch Dis Child 1998, 78:116–121.PubMedCrossRef 46. Magill RA, Waters WF, Bray GA, Volaufova J, Smith SR, Lieberman HR, McNevin N, Ryan DH: Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutr Neurosci 2003, 6:237–246.PubMedCrossRef 47. Waters WF, Magill RA, Bray GA, Volaufova J, Smith SR, Lieberman HR, Rood J, Hurry M, Anderson T, Ryan DH: A comparison of tyrosine

against placebo, Doramapimod ic50 phentermine, caffeine, and D-amphetamine during sleep deprivation. Nutr Neurosci 2003, 6:221–235.PubMedCrossRef 48. O’Brien C, Mahoney C, Tharion WJ, Sils IV, Castellani JW: Dietary tyrosine benefits cognitive and psychomotor performance during body cooling. Physiol Behav 2007, 90:301–307.PubMedCrossRef 49. Wiesel FA, Edman G, Flyckt L, Eriksson A, Nyman H, Venizelos N, Bjerkenstedt L: Kinetics of tyrosine transport and cognitive functioning in schizophrenia. Schizophr Res 2005, 74:81–89.PubMedCrossRef 50. Struder HK, Hollmann W, Platen P, Donike M, Gotzmann A, Weber K: Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine Selleckchem TPX-0005 system responses and fatigue in humans. Horm Metab Res 1998, 30:188–194.PubMedCrossRef 51. Jager R, Purpura

M, Kingsley M: Phospholipids and sports performance. J Int Soc Sports Nutr 2007, 4:5.PubMedCrossRef 52. Warber JP, Patton JF, Tharion WJ, Zeisel SH, Mello RP, Kemnitz CP, Lieberman HR: The effects of choline supplementation on physical performance. Int J Sport Nutr Lumacaftor mw Exerc Metab 2000, 10:170–181.PubMed 53. Turner EH, Loftis JM, Blackwell AD: Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther 2006, 109:325–338.PubMedCrossRef 54. Chaouloff F, Laude D, Elghozi JL: Physical exercise: evidence for differential consequences of tryptophan on 5-HT synthesis and metabolism in central serotonergic cell bodies and terminals. J Neural Transm 1989, 78:121–130.PubMedCrossRef 55. Leu-Semenescu S, Arnulf I, Decaix C, Moussa F, Clot F, Boniol C, Touitou Y, Levy R, Vidailhet M, Roze E: Sleep and rhythm consequences of a genetically induced loss of serotonin. Sleep 2010, 33:307–314.PubMed 56. Freeman MP, Helgason C, Hill RA: Selected integrative medicine treatments for depression: considerations for women. J Am Med Womens Assoc 2004, 59:216–224.PubMed 57. Larzelere MM, Wiseman P: Anxiety, depression, and insomnia. Prim Care 2002, 29:339–360. viiPubMedCrossRef 58. Thachil AF, Mohan R, Bhugra D: The evidence base of complementary and alternative therapies in depression.